BIOLASE included on 2001 Technology Fast 500 rankings

Nov. 28, 2001
BIOLASE Technology, Inc., a medical technology company focused on the dental laser market, was recently ranked 378th in Deloitte & Touche's 2001 Technology Fast 500 program.

BIOLASE Technology, Inc., a medical technology company focused on the dental laser market, was recently ranked 378th in Deloitte & Touche's "2001 Technology Fast 500" program. Rankings were based on revenue growth in the five-year period from 1996-2000.

"We have made Deloitte & Touche's 'Fast 50' for the past two years, a ranking of the fastest growing technology companies in California's Orange County and San Diego regions. We are now very proud to be selected as one of the top 500 fastest growing technology companies in the U.S. and Canada. BIOLASE continues to grow rapidly -- for the first nine months of 2001 the company's revenues exceeded $12 million, compared with $5.9 million for the first nine months of 2000. It is also gratifying that BIOLASE was recently selected as a stock pick by both the Oberweis Report and The Spear Report," commented Jeffrey W. Jones, president and chief executive officer of BIOLASE. "Moreover, the acceptance of our leading laser technology, by patients and doctors alike, continues to grow, and we look forward to further success in the years ahead."

Mark A. Evans, managing director, Deloitte & Touche Technology and Communications Group, said, "Making the Deloitte & Touche Technology Fast 500 is a testament to a company's leadership, commitment to technology, and ability to deliver the right solution at the right time. BIOLASE has proven that its leadership has the vision and determination to succeed, and we at Deloitte & Touche salute their accomplishments."

The company's Waterlase(TM) technology was recently featured on San Francisco's ABC affiliate Channel 7 News. The news segment can be accessed at: (http://abclocal.go.com/kgo/health/111601_he_painless_dentistry.html). Segments have also been filmed for upcoming news programs in Baltimore and Cleveland. News stations in Washington D.C., Philadelphia and Dallas are currently scheduling news broadcasts about the Waterlase(TM) system.